Avidity Biosciences, Inc. Quarterly Return On Equity in % from Q1 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Avidity Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2020 to Q2 2024.
  • Avidity Biosciences, Inc. Return On Equity for the quarter ending June 30, 2024 was -32.9 %, a 11.9% increase year-over-year.
  • Avidity Biosciences, Inc. annual Return On Equity for 2023 was -39.7 %, a 2.65% increase from 2022.
  • Avidity Biosciences, Inc. annual Return On Equity for 2022 was -40.8 %, a 14.7% decline from 2021.
  • Avidity Biosciences, Inc. annual Return On Equity for 2021 was -35.6 %, a 77.6% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -32.9 +4.44 +11.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -38 +2.72 +6.68% Jan 1, 2024 Mar 31, 2024
Q4 2023 -39.7 +1.08 +2.65% Oct 1, 2023 Dec 31, 2023
Q3 2023 -36.6 +6.43 +15% Jul 1, 2023 Sep 30, 2023
Q2 2023 -37.3 +1.38 +3.56% Apr 1, 2023 Jun 30, 2023
Q1 2023 -40.7 -4.45 -12.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -40.8 -5.24 -14.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -43 -12.4 -40.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -38.7 -12.2 -46.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -36.3 -16.3 -81.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -35.6 -15.5 -77.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -30.6 -0.66 -2.21% Jul 1, 2021 Sep 30, 2021
Q2 2021 -26.5 +70.8 +72.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -20 -67 -142% Jan 1, 2021 Mar 31, 2021
Q4 2020 -20 Oct 1, 2020 Dec 31, 2020
Q3 2020 -29.9 Jul 1, 2020 Sep 30, 2020
Q2 2020 -97.3 Apr 1, 2020 Jun 30, 2020
Q1 2020 47.1 Jan 1, 2020 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.